Point-of-Care Testing

News on technologies and applications for point-of-care testing.

Xylonix, BioGemex Ink MOU to Develop Point-of-Care Cancer Immunotherapy-Response Diagnostic

The two companies will work together to bring the point-of-care pretreatment diagnostic based on the XDX-01 biomarker to market in 2020.

Georgia Tech, Emory Developing Urine-Based Dx to Guide Cancer Immunotherapies

Premium

The biological activity sensors in development consist of nanoparticles conjugated with a peptide substrate produce fluorescence in urine associated with immunotherapy response.

Menu

Point-of-Care Testing

Xylonix, BioGemex Ink MOU to Develop Point-of-Care Cancer Immunotherapy-Response Diagnostic

Georgia Tech, Emory Developing Urine-Based Dx to Guide Cancer Immunotherapies

Breaking News

Biofidelity Awarded £500K Innovate UK Grant to Develop Noninvasive MDx Tools

Gestalt Diagnostics Enters Collaborations on Cancer Pathology Testing

Study Finds Breast, Ovarian Cancer Gene Tests Cost-Effective for Unselected Breast Cancer Patients

Predictive Oncology Prices $3.2M Public Offering

Agilent Technologies PD-L1 IHC Assay Approved by China Regulators

SEngine Precision Medicine Raises $5.1M in Series A Financing

Single-Cell Methylation Profiling of Pediatric Tumors via a Unique NGS-based Approach

Sponsorships